Literature DB >> 7658233

Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.

A H Maurer1, D F Caroline, F J Jadali, T A Manzone, W P Maier, F C Au, S F Schnall.   

Abstract

UNLABELLED: Previous studies with 201Tl and 99mTc-sestamibi (MIBI) have used large field of view (LFOV) cameras not optimized for breast imaging. The purpose of this study was to compare these agents and to determine if a small field of view (SFOV) camera designed to minimize the camera-to-breast distance could improve tumor detection.
METHODS: A 28-cm (SFOV) camera was fitted with slant-hole and diverging collimators to perform craniocaudal scintigraphy for direct comparison with mammography. Of the 46 patients studied, 20 had 201Tl imaging alone and 26 had combined 201Tl and MIBI imaging. LFOV (40 cm) breast and axillary images also were obtained. Visual and quantitative analyses of tumor uptake were performed.
RESULTS: The SFOV camera with nonparallel collimation showed variable 201Tl and MIBI normal breast activity. This was partly due to significant scatter from cardiac and abdominal activity. Overall, 201Tl had a sensitivity of 53%, which was 67% for tumors > or = 1.5 cm and 20% for tumors < or = 1.5 cm. MIBI sensitivity was 90% (9/10) for lesions > or = 1.5 cm. Specificity was 93% for 201Tl and 83% for MIBI. There was no significant difference in 201Tl (1.76 +/- 0.55) and MIBI (1.82 +/- 0.95) tumor uptake ratios (p = 0.75).
CONCLUSION: Technetium-99m-MIBI was more sensitive than 201Tl for imaging lesions > or = 1.5 cm. Craniocaudal positioning minimized the camera-to-breast distance but did not increase 201Tl detection of tumors < 1.5 cm and increased background breast activity due to scatter.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658233

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2007-04-01

2.  99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice.

Authors:  Zhonglin Liu; Gail D Stevenson; Harrison H Barrett; George A Kastis; Michel Bettan; Lars R Furenlid; Donald W Wilson; James M Woolfenden; Koon Yan Pak
Journal:  Nucl Med Commun       Date:  2004-07       Impact factor: 1.690

Review 3.  The role of nuclear medicine in breast cancer detection: a focus on Technetium-99 Sestamibi scintimammography.

Authors:  Lina Romero; Iraj Khalkhali; Hernan I Vargas
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

4.  Limits of Tumor Detectability in Nuclear Medicine and PET.

Authors:  Yusuf Emre Erdi
Journal:  Mol Imaging Radionucl Ther       Date:  2012-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.